Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/11180
Title: | Hepatic p63 regulates steatosis via IKKβ/ER stress. |
Authors: | Porteiro, Begoña Fondevila, Marcos F Delgado, Teresa C Iglesias, Cristina Imbernon, Monica Iruzubieta, Paula Crespo, Javier Zabala-Letona, Amaia Fernø, Johan González-Terán, Bárbara Matesanz, Nuria Hernández-Cosido, Lourdes Marcos, Miguel Tovar, Sulay Vidal, Anxo Sánchez-Ceinos, Julia Malagon, Maria M Pombo, Celia Zalvide, Juan Carracedo, Arkaitz Buque, Xabier Dieguez, Carlos Sabio, Guadalupe López, Miguel Aspichueta, Patricia Martínez-Chantar, María L Nogueiras, Ruben |
metadata.dc.subject.mesh: | Adult Animals Endoplasmic Reticulum Stress Fatty Liver Female Hepatocytes Humans I-kappa B Kinase Lipid Metabolism Liver Male Mice Mice, Inbred C57BL Mice, Knockout Middle Aged Phosphoproteins Trans-Activators Transcription Factors Tumor Suppressor Proteins X-Box Binding Protein 1 |
Issue Date: | 8-May-2017 |
Abstract: | p53 family members control several metabolic and cellular functions. The p53 ortholog p63 modulates cellular adaptations to stress and has a major role in cell maintenance and proliferation. Here we show that p63 regulates hepatic lipid metabolism. Mice with liver-specific p53 deletion develop steatosis and show increased levels of p63. Down-regulation of p63 attenuates liver steatosis in p53 knockout mice and in diet-induced obese mice, whereas the activation of p63 induces lipid accumulation. Hepatic overexpression of N-terminal transactivation domain TAp63 induces liver steatosis through IKKβ activation and the induction of ER stress, the inhibition of which rescues the liver functions. Expression of TAp63, IKKβ and XBP1s is also increased in livers of obese patients with NAFLD. In cultured human hepatocytes, TAp63 inhibition protects against oleic acid-induced lipid accumulation, whereas TAp63 overexpression promotes lipid storage, an effect reversible by IKKβ silencing. Our findings indicate an unexpected role of the p63/IKKβ/ER stress pathway in lipid metabolism and liver disease. |
URI: | http://hdl.handle.net/10668/11180 |
metadata.dc.identifier.doi: | 10.1038/ncomms15111 |
Appears in Collections: | Producción 2020 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
PMC5424198.pdf | 6,28 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License